The Global Oncology Drugs Market is expected to register a CAGR of 7.3%, reaching a value of around USD 223 billion by the end of 2027.
Oncology is the branch of science deals with cancer and related treatment. Cancer or malignancy is referred to as the group of the diseases characterized by uncontrolled or abnormal growth of the cells. Oncology drugs or cancer drugs are dedicated to controlling, inhibiting or to kill the uncontrollable carcinogenic cells. These drugs can be prescribed alone or with any combination treatment or therapy. It includes chemotherapy, targeted therapy, pain killer, hormone therapy and immunotherapy.
Market Driver:
The growing prevalence of cancer in global population creates an impact on the healthcare industry and society across the world. Cancer has gained the second position in the fatal diseases following cardiovascular diseases and contributing immensely to the global death rate with a remarkable rise in the incidence of new cases globally. In 2018, the World Health Organization stated that around 18.1 million fresh cases of cancer were reported. Whereas, American Cancer Society revealed that cancer is accountable for one in the six death globally. The incidence of fatal diseases can be attributed to various factors including growth in global population and increasing count of the elderly population. Cancer Research UK stated over three-quarters of the total cancer population is over 60 years. Smoking, life-style related factors, exposure to radioactive chemicals, and genetic factor further favors the incidence of the new cancer cases. . With the growing cancer cases worldwide, the oncology drugs market is growing at a robust rate
Market Challenge:
Different type of cancer drugs leads to different types of side effects including anemia, anorexia, infections, diarrhea, oral problems, weight loss, nausea and many more resulting in discomfort and extreme pain. Some of the treatment and drugs leave a long term impact including early menopause in females, extreme fatigue and impacting cognitive functioning. Due to serious side effects associated with the cancer drugs is expected to witness a roadblock for the oncology drug market.
The report on the Oncology Drugs market covers a deep dive analysis of historic, recent and current market trends. Furthermore, market share/ranking analysis of key players, market dynamics, competition landscape, country-wise analysis for each region covered and the entire supply chain dynamics are covered through the below segmentation.
Report Features |
Specifics |
---|---|
Historical/Estimated/Forecasted Market Size Years |
2018-2027 |
Base Year for Market Calculation |
2019 |
Forecasted Period |
2020-2027 (2020 estimated year, forecasted up to 2027) |
Measured Units |
Value (USD Million) |
Segments Included |
Form, Type and Cancer Type, and Region |
Regional Coverage |
North America, Asia-Pacific, Europe, Middle East & Africa, South America |
For the scope of the report, In-depth segmentation is offered by Forencis Research
Oncology Drugs Market, by Form
Oncology Drugs Market, by Type
Oncology Drugs Market, by Cancer Type
Oncology Drugs Market, by Region
60+ MARKET TABLES AND 30+ FIGURES WILL BE INCLUDED IN THE ONCOLOGY DRUGS MARKET STUDY
Note1: Tentative table of contents, may get updated during the course of research.
Note2: Company financial information is subject to availability in public domain
60+ MARKET TABLES AND 30+ FIGURES WILL BE INCLUDED IN THE STUDY